Tavotek Biotherapeutics

About:

Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.

Website: https://tavotek.com/

Top Investors: New Alliance Capital, Oriza Holdings, BioVenture, CTS Capital, GF Xinde Investment Management

Description:

Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Our company management and advisors consist of veteran pharmaceutical executives with multiple prior successes in the development of many blockbuster biologics currently in the market. Tavotek has 3 diverse R&D platform for biologics: TavoSelect (an innovative Phage Display Library), TavoPrecise (engineering platform for tissue-specific biologics), and TavoMIP (a multicyclic peptide platform). Along with these platforms, Tavotek has a rich and diverse pipeline of product candidates in various stages of development, focused on cancers, autoimmune conditions, and infectious diseases.